Registered drugs

You can find information about a therapy by entering a name or keyword in the search box and/or refine your search by selecting one of the categories below.
Therapies with the icon Book icon are more extended.

Cabozantinib

Cabozantinib (Cabometyx) is a cancer medicine used to treat adults with advanced renal cell carcinoma who have been previously treated with a type of cancer medicine called a ‘vascular endothelial growth factor (VEGF) inhibitor’

Radium Ra 223 dichloride

Radium RA 223 dichloride (xofigo) is an anticancer drug used to treat prostate cancer with metastases to the bones after they had hormonal treatment. It delivers radiation to bone tumors.

Afatinib

Afatinib is the active substance in Giotrif®. It is used to treat a type of lung cancer known as non-small cell lung cancer.

Aflibercept

Aflibercept is the active ingredient in Zaltrap®. Zaltrap® is used to treat adults with metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body) for whom treatment based on another medicine, oxaliplatin, has notworked or the cancer got worse.

Bosutinib

Bosutinib is the active substance of Bosulif®. Bosulif® is an anticancer medicine that contains the active substance bosutinib. It is used to treat adults with chronic myeloid leukaemia (CML), a cancer of the white blood cells in which granulocytes (a type of white blood cell) start growing out of control.

Dabrafenib

Dabrafenib is the active substance in Tafinlar®. It is used to treat adults with non-small cell lung cancer (NSCLC) as well as melanoma (a type of skin cancer) that has spread to other parts of the body or cannot be surgically removed.

Enzalutamide

Enzalutamide is the active substance in Xtandi®. Xtandi® is an anticancer medicine that contains the active substance enzalutamide. It is used to treat adult men with cancer of the prostate (a gland of the male reproductive system).

Ibrutinib

An anticancer medication used to treat chronic lymphocytic leukemia as well as a rare form of non-Hodgkin lymphoma called mantle cell lymphoma. Its use is recommended when at least one medication has been used previously. It works by inhibiting an enzyme that cancer cells need to multiply and spread.

Pertuzumab

Pertuzumab is the active substance in Perjeta®. Perjeta® is used to treat adults with breast cancer which is ‘HER2-positive’ (where a specific protein called ‘HER2’ is found on the surface of the cancer cells) and is metastatic (has spread to other parts of the body) or has come back after treatment and cannot be removed by surgery.

Pomalidomide

Pomalidomide is the active substance in Imnovid®. It is used in combination with dexamethasone (an anti-inflammatory medicine) to treat multiple myeloma (a cancer of the bone marrow). It is used in adults who have received at least two prior therapies, including both lenalidomide and bortezomib, and whose disease progressed after the last treatment.